Research and development expense was USD 18.2 million against USD 10.5 million, and general and administrative expense was USD 9.1 million against USD 4.4 million. The filing attributes about USD 6.9 million of the research increase to development of ALTO-207, which the company acquired …
Management said third quarter revenue increased 17% from the prior year and year to date revenue increased 12%. The nine month net income attributable to the company was USD 1,080,000, or USD 0.05 per share, and the filing states that this figure includes a …
Gross profit increased by USD 1,069,000, or 18.2%, to USD 6,937,000. TheGross Profitmargin was 41.8% against 39.7% a year earlier. Income from operations was USD 1,970,000 against USD 1,097,000.
The filing states spectrum revenue rose USD 0.4 million, or 26%, to USD 2.0 million. Management saidGAAPrevenue was about USD 2 million and operating expenses were about USD 9.4 million, and the company also recorded a USD 6.1 million gain on license exchanges in …
The accumulatedDeficitwas USD 270.3 million. Cash and cash equivalents were USD 20.6 million at September 30, withWorking Capitalof USD 20.5 million.
For the nine months, the company reported a net loss of USD 11.2 million againstNet Incomeof USD 36.1 million in the prior-year period. The filing states commercialization revenue in the current period relates solely to ongoing regulatory activities and clinical vial sales, resulting in …
Gross profit increased 46% to USD 94 million, or 34.6% of sales. Operating income doubled to a record USD 54 million, or 19.9% of sales, and adjusted operating income was USD 51 million.
Adjusted EBITDA was USD 6.0 million, or 5.9% of revenue. GrossMarginwas 29.6% on both a GAAP and non-GAAP basis. GAAP operating expenses were USD 29.3 million, and non-GAAP operating expenses were USD 26.2 million.
For the nine months, net loss was USD 78.50 million against USD 65.20 million, and loss per share was USD 0.85 against USD 1.80.
Management said total revenues increased to USD 10.9 million, of which smart cart revenues more than doubled sequentially to USD 9.6 million, reflecting growing deliveries across multiple customers. Third quarter net loss was USD 6.6 million, or USD 0.15 per share, compared with a …